FCVAX
Price
$24.74
Change
+$0.03 (+0.12%)
Updated
Aug 13 closing price
Net Assets
5.47B
SSGSX
Price
$54.37
Change
+$0.13 (+0.24%)
Updated
Aug 13 closing price
Net Assets
4.5B
Interact to see
Advertisement

FCVAX vs SSGSX

FCVAX vs SSGSX Comparison Chart in %
View a ticker or compare two or three
VS
FCVAX vs. SSGSX commentary
Aug 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FCVAX is a StrongBuy and SSGSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FCVAX has more cash in the bank: 5.47B vs. SSGSX (4.5B). FCVAX pays higher dividends than SSGSX: FCVAX (0.66) vs SSGSX (0.52). FCVAX was incepted earlier than SSGSX: FCVAX (22 years) vs SSGSX (27 years). SSGSX (1.23) and FCVAX (1.20) have similar cost to investors . FCVAX is a more actively managed with annual turnover of: 96.00 vs. SSGSX (50.00). FCVAX (6%) and SSGSX (6%) have equivalent initial investment costs. FCVAX has a lower initial minimum investment than SSGSX: FCVAX (0) vs SSGSX (2500). FCVAX annual gain was more profitable for investors over the last year : 21.42 vs. SSGSX (17.08). FCVAX return over 5 years is better than : 18.60 vs. SSGSX (-0.48).
FCVAXSSGSXFCVAX / SSGSX
Total Expense Ratio1.201.2398%
Annual Report Gross Expense Ratio1.201.2398%
Fund Existence22 years27 years-
Gain YTD28.69821.369134%
Front Load6%6%100%
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets5.47B4.5B122%
Annual Yield % from dividends0.660.52128%
Returns for 1 year21.4217.08125%
Returns for 3 years32.5614.09231%
Returns for 5 years18.60-0.48-3,855%
Returns for 10 years42.1340.12105%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GPRO0.630.06
+9.84%
GoPro
GPK11.840.15
+1.28%
Graphic Packaging Holding Company
DGICA18.750.10
+0.54%
Donegal Group
KOF108.84-1.03
-0.94%
Coca-Cola FEMSA SAB DE CV
CURX0.22-0.01
-2.92%
Curanex Pharmaceuticals Inc.